MarketScreener Homepage > Equities > Nyse > Abbott Laboratories ABT

Report

Delayed Nyse - 11/24 04:10:00 pm
107.61	USD		-1.52%

11/20

ABBOTT LABORATORIES : Change in Directors or Principal Officers (form 8-K)

11/19

ABBOTT LABORATORIES : Becomes first anchor sponsor of american diabetes association's health equity now initiative to advance access to care and technology for people with diabetes

11/18

ABBOTT LABORATORIES : Launches the first infant formula in canada with an ingredient identical in structure to immune component found in breast milk

Summary

The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.

Strengths

The group's high margin levels account for strong profits.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the past twelve months, EPS forecast has been revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The tendency within the weekly time frame is positive above the technical support level at 88.71 USD

Weaknesses

Stock prices approach a strong long-term resistance in weekly data at USD 114.42.
The group usually releases earnings worse than estimated.
The company's enterprise value to sales, at 6.07 times its current sales, is high.
The company benefits from high valuations in earnings multiples.
The company is not the most generous with respect to shareholders' compensation.

Ratings chart

Sector Medical Equipment, Supplies & Distribution - NEC



MEDTRONIC PLC	-2.19%	149 189
BECTON, DICKINSON AND COMPA..	-15.99%	66 229
HOYA CORPORATION	25.50%	44 928
BAXTER INTERNATIONAL INC.	-9.39%	38 705
ALIGN TECHNOLOGY, INC.	70.79%	37 579
SARTORIUS STEDIM BIOTECH	101.08%	32 342
DEXCOM, INC.	46.79%	30 834
ZIMMER BIOMET HOLDINGS	-2.30%	30 250
TERUMO CORPORATION	7.93%	29 380
WEST PHARMACEUTICAL SERVICE..	89.40%	21 049
AMERISOURCEBERGEN CORPORATI..	18.16%	20 523
SYSMEX CORPORATION	37.27%	20 318
STERIS PLC	24.06%	16 728
BIO-RAD LABORATORIES, INC.	49.98%	16 566
AVANTOR, INC.	42.70%	14 979

Analysis

Financials (USD)

Upcoming event on ABBOTT LABORATORIES

01/27/21

Fundamental ratings

Technical ratings